SIC 2836 – Biological Products, Except Diagnostic Substances (Biotech)
| Valuation | |
|---|---|
| Market Cap ($M) | 2,618.07 |
| Enterprise Value ($M) | 2,454.88 |
| Book Value ($M) | 773.46 |
| Book Value / Share | 2.54 |
| Price / Book | 3.38 |
| NCAV ($M) | 280.92 |
| NCAV / Share | 0.92 |
| Price / NCAV | 9.32 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -0.48 |
| Return on Assets (ROA) | -0.48 |
| Return on Equity (ROE) | -0.61 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 3.90 |
| Current Ratio | 4.22 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 498.58 |
| Assets | 991.12 |
| Liabilities | 217.66 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 0.00 |
| Operating Income | 0.00 |
| Net Income | 0.00 |
| Earnings Per Share Basic And Diluted | n/a |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | 0.00 |
| Cash from Investing | 0.00 |
| Cash from Financing | 0.00 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G/A | Perceptive Advisors Llc | 8.80 | 38.48 | |
| 13G/A | State Street Corp | 4.40 | -19.62 | |
| 13D/A | Quogue Capital LLC | 11.60 | 20.00 | |
| 13G/A | Point72 Asset Management, L.P. | 0.20 | -94.22 | |
| 13G/A | Vanguard Group Inc | 8.91 | 57.73 | |
| 13G/A | Mhr Fund Management Llc | 7.80 | 66.20 | |
| 13G/A | BlackRock, Inc. | 7.50 | 57.93 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| File Date | Form | SEC Filings |
|---|---|---|
| +- UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q | ||
| +- UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q | ||
| +- UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 Form 10-K | ||
(click for more detail) |
||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 2,257,389 | 7,661,226 | 29.47 | |
| 1,675,745 | 6,095,101 | 27.49 | |
| 2,163,210 | 8,596,826 | 25.16 | |
| 2,195,802 | 8,253,454 | 26.60 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| IKNA – Ikena Oncology, Inc. | IMRX – Immuneering Corporation |
| INAB – IN8bio, Inc. | IPA – ImmunoPrecise Antibodies Ltd. |
| IRON – Disc Medicine, Inc. |
Financial data and stock pages provided by
Fintel.io